The Importance of Pursuing the PRRF Mission
Dr. Michael Trese shares why pursuing the PRRF mission is so important to the future of children, families and future patients.
Championing Hope: Supporting Families and Pursuing Cures for Pediatric Retinal Diseases
The mission of the Pediatric Retinal Research Foundation (PRRF) is to raise awareness of pediatric retinal diseases, drive research, and support the community of affected individuals and their families.
We aspire to transform lives through cure-focused translational research, and to empower those impacted by rare pediatric retinal diseases to realize their full potential.
The Foundation is guided by six core values that define who we are and how we strive to make an impact: Excellence, Innovation, Advocacy, Engagement, Inclusion, and Compassion. These values shape our actions and reflect our commitment to serving our community with integrity and purpose.
Prior to his current role, Dobin was the director and head of the HR business advisory team, responsible for HR employee relations functions across the US and Canada. Prior to that role, Dobin served as a senior HR business partner, where he was responsible for providing counsel regarding employment & labor relations, leadership development, training, mergers & acquisitions, succession planning, targeted recruiting, and organizational effectiveness for multiple business units with corporate and operational responsibilities. Dobin has held multiple roles with expanded scope during his tenure at NextEra Energy, Inc.
Prior to joining NextEra Energy in 2015, Dobin served as the corporate HR manager for North American Programs at Office Depot, Inc., responsible for HR initiatives, program design and implementation with the U.S. retail division. He also worked for the Target Corporation in multiple roles with increasing responsibility in the HR, investigation, safety and assets protection divisions, ultimately serving as a senior manager for HR and market resource leader.
Dobin serves as board vice president of Families First of Palm Beach County, vice president of operations of the Pediatric Retinal Research Foundation and a director of CareerSource Palm Beach County. He holds a bachelor’s degree in business administration and management from Florida Atlantic University and is a graduate of Leadership Palm Beach County, class of 2021 where he also served as a governor (2022-2024). Dobin resides in Palm Beach County, Florida with his wife and two children.
A graduate of University of Detroit High School, Albion College (Economics) and the University of Detroit (JD and MBA combined program), Bob is a CFA charter holder, an attorney and a member of the CFA Society of Detroit. Bob and his wife, Anne, have two great kids, Ellen and Daniel. Bob is recently retired and enjoys skiing, cycling and tennis.
Dr. Trese is an active member of the American Academy of Ophthalmology, American Society of Retina Specialists, Association for Research in Vision and Ophthalmology, and Michigan Society of Eye Physicians and Surgeons. He graduated from Michigan State University with a Doctorate in Osteopathic Medicine and Boston University School of Medicine with a Master of Art’s in Medical Sciences. Additionally, he is the son of PRRF Founder, Dr. Michael Trese, and is passionate about honoring his father’s legacy through his involvement in the Foundation.
She is passionate about elevating mission-driven brands and using social media to do social good. She works with nonprofit, philanthropy, and mission-driven private sector clients to increase brand visibility, polish messaging, produce engaging creatives, rally communities, and rigorously measure our results.
Dr. Trese is widely considered the father of modern pediatric vitreoretinal surgery. In a career spanning more than 40 years, he has been credited with significant breakthroughs and has taught many of today’s leading pediatric retina specialists.
In the 1980s, he revolutionized pediatric vitreoretinal surgery with his concept of lens-sparing vitrectomy for the treatment of complex pediatric retinal detachment due to advanced retinopathy of prematurity (ROP). His techniques have also been applied to diseases such as familial exudative vitreoretinopathy, juvenile X-linked retinoschisis and Coats disease. He led the way to the first FDA-approved drug for pharmacologic vitreolysis.
In addition to his achievements as a medical doctor, his impact on families world-wide through the work of the Foundation is significant. He championed early translational research in the quest for cures, was instrumental in bringing to reality the only research lab dedicated solely to pediatric retinal research and provided hope to countless families. We will continue this work in honor of our Founder, friend and colleague.
Dr. Michael Trese shares why pursuing the PRRF mission is so important to the future of children, families and future patients.